StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)

Stock analysts at StockNews.com initiated coverage on shares of Jaguar Health (NASDAQ:JAGX) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Jaguar Health Trading Down 7.2 %

Shares of Jaguar Health stock opened at $0.23 on Thursday. Jaguar Health has a 52 week low of $0.20 and a 52 week high of $21.60. The business’s fifty day simple moving average is $0.73 and its 200-day simple moving average is $0.96. The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65.

Hedge Funds Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC bought a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.22% of Jaguar Health at the end of the most recent quarter. Institutional investors own 12.04% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.